Nafeesa N. N. Dhalwani

Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study

2023 | Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové

Publication